Skip to main content
. 2016 Dec 15;1(6):e000084. doi: 10.1136/esmoopen-2016-000084

Figure 8.

Figure 8

Kinetics of serum tumor marker concentrations CEA and CA 19-9: from initiation of therapy in September 2015 to completion of 11 cycles pembrolizumab in late March 2016.